Streetbeat News

Stock Prices

MAIN

Main Street Capital's short interest has increased by 10.16%, with 4.10 million shares sold short, representing 4.88% of its float. This is higher than its peers' average of 3.54%. The rise in short interest suggests bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

CVNA

Carvana (NYSE:CVNA) has delivered an impressive annualized return of 20.63% over the past 5 years, outperforming the market by 6.32%. A $1000 investment in Carvana 5 years ago would now be worth $2,594.09, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

SKX

Skechers USA (NYSE:SKX) has seen a 9.09% decrease in its short percent of float, now at 5.5% of available shares. This is lower than the peer group average of 6.84%. The decrease in short interest may indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

BX

Blackstone (NYSE:BX) has significantly outperformed the market over the past 5 years, with an annualized return of 26.59%. A $1000 investment in BX 5 years ago would now be worth $3,142.30. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

PINS

Pinterest's short interest has increased by 4.32%, with 18.85 million shares sold short, representing 3.14% of its float. This is below the peer group average of 7.04%. The rise in short interest suggests a more bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

CARA

EAST

OGI

SMG

UGRO

XXII

The cannabis sector experienced mixed movements on September 26, 2024, with some stocks gaining and others losing. Notable gainers included Urban-gro, Cara Therapeutics, Scotts Miracle Gro, and OrganiGram Holdings. Meanwhile, 22nd Century Group and Eastside Distilling were among the notable losers.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

CUE

Cue BioPharma's shares are declining following the announcement of a proposed public offering.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:29 pm

CUE

Cue Biopharma has announced a proposed public offering, though the terms have not been disclosed. This move could impact the company's stock price as investors react to the news.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:28 pm

VINP

Vinci Partners Investments has approved a $15 million buyback program, as per an SEC filing. This move indicates confidence in the company's stock value and could positively impact its share price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:25 pm

AYTU

Aytu BioPharma reported a Q4 2024 GAAP EPS of $(0.82), missing the $(0.45) estimate, and sales of $18.00M, missing the $18.30M estimate. This represents a 41.43% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:24 pm